Efgartigimod efficacious, safe for primary immune thrombocytopenia
The first-in-class novel human immunoglobulin G1 Fc fragment, efgartigimod, is efficacious and safe for patients with chronic or persistent primary ...
Read moreThe first-in-class novel human immunoglobulin G1 Fc fragment, efgartigimod, is efficacious and safe for patients with chronic or persistent primary ...
Read more© 2023 earth-news.info